Announced its ONE by ONE and Biotrue Eye Care Recycling programs have been recognized as 2023 Sustainability ...
Announced the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalmic solution) for the treatment ...
Today announced that Chairman and CEO Brent Saunders is scheduled to participate at the 2023 Wells Fargo ...
Announced the U.S. launch of PreserVision® AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10). Developed ...
Announced a reshaping of its executive leadership team, including the elevation of all business unit ...
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21 podium...
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election...
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of StableVisc™...